1. Home
  2. RICK vs SGMT Comparison

RICK vs SGMT Comparison

Compare RICK & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCI Hospitality Holdings Inc.

RICK

RCI Hospitality Holdings Inc.

HOLD

Current Price

$24.72

Market Cap

211.0M

ML Signal

HOLD

Logo Sagimet Biosciences Inc. Series A

SGMT

Sagimet Biosciences Inc. Series A

HOLD

Current Price

$5.54

Market Cap

169.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
RICK
SGMT
Founded
1983
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
211.0M
169.4M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
RICK
SGMT
Price
$24.72
$5.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$98.00
$26.38
AVG Volume (30 Days)
77.5K
358.0K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
1.14%
N/A
EPS Growth
272.73
N/A
EPS
1.23
N/A
Revenue
$144,896,000.00
$2,000,000.00
Revenue This Year
$19.32
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.76
$2.02
52 Week High
$43.21
$11.41

Technical Indicators

Market Signals
Indicator
RICK
SGMT
Relative Strength Index (RSI) 57.90 54.76
Support Level $23.71 $4.97
Resistance Level $25.07 $6.08
Average True Range (ATR) 1.17 0.35
MACD 0.19 0.08
Stochastic Oscillator 84.82 80.70

Price Performance

Historical Comparison
RICK
SGMT

About RICK RCI Hospitality Holdings Inc.

RCI Hospitality Holdings Inc through its subsidiaries owns and operates establishments that offer live adult entertainment, restaurant, and or bar operations. It also owns and operates a communication company serving the adult nightclub industry. The company's operating business segments are Nightclubs, Bombshells, and Others. It operates nightclubs through the following brands Rick's Cabaret, Vivid Cabaret, Tootsie's Cabaret, Club Onyx, and Jaguars Club. In the Bombshells segment, the company is building a chain of Restaurants and Sports Bars in Dallas, Austin, and Houston, Texas. It derives the majority of revenue from the Nightclubs segment that engages in the sale of alcoholic beverages, food, and merchandise items; service in the form of cover charges, dance fees, and room rentals.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

Share on Social Networks: